6-51748086-A-G

Position:

chr6-51748086-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5

The NM_138694.4(PKHD1):c.9530T>C(p.Ile3177Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000917 in 1,613,662 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)

Exomes 𝑓: 0.000096 ( 0 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:8U:3

Conservation

PhyloP100: 6.10

Variant links:

Genes affected

PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

PKHD1 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2

Very rare variant in population databases, with high coverage;

PP5

Variant 6-51748086-A-G is Pathogenic according to our data. Variant chr6-51748086-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 377018.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=5, Uncertain_significance=2, Pathogenic=2}. Variant chr6-51748086-A-G is described in Lovd as [Pathogenic]. Variant chr6-51748086-A-G is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
PKHD1	NM_138694.4 linkuse as main transcript	c.9530T>C	p.Ile3177Thr	missense_variant	58/67	ENST00000371117.8	NP_619639.3

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
PKHD1	ENST00000371117.8 linkuse as main transcript	c.9530T>C	p.Ile3177Thr	missense_variant	58/67	1	NM_138694.4	ENSP00000360158	P2	P08F94-1
PKHD1	ENST00000340994.4 linkuse as main transcript	c.9530T>C	p.Ile3177Thr	missense_variant	58/61	5		ENSP00000341097	A2	P08F94-2

Frequencies

GnomAD3 genomes

AF:

0.0000460

AC:

AN:

152216

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000241

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000882

Gnomad OTH

AF:

0.00

GnomAD3 exomes

AF:

0.0000518

AC:

AN:

250878

Hom.:

AF XY:

0.0000369

AC XY:

AN XY:

135538

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad SAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.000115

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000965

AC:

141

AN:

1461446

Hom.:

Cov.:

AF XY:

0.0000825

AC XY:

AN XY:

727056

show subpopulations

Gnomad4 AFR exome

AF:

0.00

Gnomad4 AMR exome

AF:

0.00

Gnomad4 ASJ exome

AF:

0.00

Gnomad4 EAS exome

AF:

0.00

Gnomad4 SAS exome

AF:

0.00

Gnomad4 FIN exome

AF:

0.00

Gnomad4 NFE exome

AF:

0.000125

Gnomad4 OTH exome

AF:

0.0000331

GnomAD4 genome

AF:

0.0000460

AC:

AN:

152216

Hom.:

Cov.:

AF XY:

0.0000403

AC XY:

AN XY:

74378

show subpopulations

Gnomad4 AFR

AF:

0.0000241

Gnomad4 AMR

AF:

0.00

Gnomad4 ASJ

AF:

0.00

Gnomad4 EAS

AF:

0.00

Gnomad4 SAS

AF:

0.00

Gnomad4 FIN

AF:

0.00

Gnomad4 NFE

AF:

0.0000882

Gnomad4 OTH

AF:

0.00

Alfa

AF:

0.0000807

Hom.:

TwinsUK

AF:

0.00

AC:

ALSPAC

AF:

0.000519

AC:

ESP6500AA

AF:

0.00

AC:

ESP6500EA

AF:

0.000116

AC:

ExAC

AF:

0.0000412

AC:

EpiCase

AF:

0.0000545

EpiControl

AF:

0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:8Uncertain:3

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

not provided

Pathogenic:4Uncertain:1

Likely pathogenic, criteria provided, single submitter	clinical testing	GeneDx	Mar 22, 2021	Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31980526, 30507656, 19940839, 30595564, 15698423, 12846734, 15108281, 18503009, 30650191, 16133180, 19914852, 15108277, 12874454) -
Pathogenic, criteria provided, single submitter	clinical testing	Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics	Jan 06, 2017	- -
Uncertain significance, no assertion criteria provided	research	Gharavi Laboratory, Columbia University	Sep 16, 2018	- -
Likely pathogenic, criteria provided, single submitter	clinical testing	Mayo Clinic Laboratories, Mayo Clinic	Nov 25, 2019	PM2, PM3, PP1, PP4, PP5 -
Pathogenic, no assertion criteria provided	clinical testing	Department of Pathology and Laboratory Medicine, Sinai Health System	-	The PKHD1 p.Ile3177Thr variant was identified in 10 of 974 proband chromosomes (frequency: 0.01) from individuals or families with ARPKD (Bergmann 2005, Denamur 2010, Furu 2004, Gunay-Aygun 2010, Losekoot 2005, Rosetti 2003).The variant was also identified in dbSNP (ID: rs200511261), Clinvitae database (as pathogenic by Emory genetics) RWTH AAachen University ARPKD database (as pathogenic) and PKHD1-LOVD. This variant was identified in the NHLBI GO Exome Sequencing Project in 1 of 8600 European American alleles (freq. 0.0001) and Exome Aggregation Consortium database (March 14, 2016) in 5 of 66720 chromosomes (freq. 7.49E-05) in the European population, this low number of observations and low frequency is not substantive enough to determine the prevalence of the variant in the general population and its relationship to disease. The p.Ile3177 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. The case studies by Arbeiter (2008) and Denamur (2010) identify this mutation along with evolutionarily highly conserved missense change c.2414CT (p.Pro805Leu) in patients who died perinatally from ARPKD. In addition, several studies found the variant in patients with severe perinatally-fatal phenotype of ARPKD (Bergmann 2005, Furu 2004, Gunay-Aygun 2010, Rosetti 2003, Losekoot 2005). In summary, based on the above information, this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic. -

Autosomal recessive polycystic kidney disease

Pathogenic:2Uncertain:1

Likely pathogenic, criteria provided, single submitter	clinical testing	Fulgent Genetics, Fulgent Genetics	Oct 31, 2018	- -
Pathogenic, criteria provided, single submitter	clinical testing	Baylor Genetics	-	- -
Uncertain significance, criteria provided, single submitter	clinical testing	Labcorp Genetics (formerly Invitae), Labcorp	Jan 21, 2024	This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 3177 of the PKHD1 protein (p.Ile3177Thr). This variant is present in population databases (rs200511261, gnomAD 0.01%). This missense change has been observed in individual(s) with polycystic kidney disease on the same chromosome with another PKHD1 variant (p.Pro805Leu)(PMID: 16133180, 15108281, 18503009, 19940839). The haplotype (Pro805Leu; Ile3177Thr) has been observed on the opposite chromosome from other pathogenic variants in an individuals affected with polycystic kidney disease (PMID: 12846734, 15108281, Invitae). ClinVar contains an entry for this variant (Variation ID: 377018). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PKHD1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Polycystic kidney disease 4

Pathogenic:2

Likely pathogenic, criteria provided, single submitter	clinical testing	Baylor Genetics	Feb 24, 2024	- -
Likely pathogenic, criteria provided, single submitter	clinical testing	Johns Hopkins Genomics, Johns Hopkins University	Mar 10, 2021	This PKHD1 variant (rs200511261) is rare (<0.1%) in a large population dataset (gnomAD: 13/250878 total alleles; 0.005%; no homozygotes) and has an entry in ClinVar. It has been observed on the opposite chromosome from other pathogenic variants in individuals affected with PKD4. Two bioinformatics tools queried predict that p.Ile3177Thr would be tolerated, while another predicts it would be damaging. The isoleucine residue at this position is partially conserved across the vertebrate species assessed; some species have a valine substitution at this position. This variant is not predicted to affect normal exon 58 splicing, although this has not been confirmed experimentally to our knowledge. We consider c.9530T>C to be likely pathogenic. -

PKHD1-related disorder

Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

PreventionGenetics, part of Exact Sciences

Mar 13, 2023

The PKHD1 c.9530T>C variant is predicted to result in the amino acid substitution p.Ile3177Thr. This variant has been reported in several patients with polycystic kidney disease. In the majority of patients, it was detected in combination with the PKHD1 variant c.2414C>T (p.Pro805Leu) (Rossetti et al. 2003. PubMed ID: 12846734; Shuster et al. 2019. PubMed ID: 30650191; Bergmann et al. 2004. PubMed ID: 15108281; Denamur et al. 2010. PubMed ID: 19940839; PreventionGenetics). In at least four of these patients familial testing confirmed these variants were inherited as a haplotype (in cis) on the same allele (c.[2414C>T;9530T>C] p.[Pro805Leu;Ile3177Thr]), and this haplotype was in trans with a second PKHD1 variant allele (Rossetti et al. 2003. PubMed ID: 12846734 ; Shuster. 2019. PubMed ID: 30650191; Bergmann et al. 2004. PubMed ID: 15108281). However, the c.9530T>C (p.Ile3177Thr) variant has also been reported in individuals with polycystic kidney disease without p.Pro805Leu (Rossetti et al. 2003. PubMed ID: 12846734; PreventionGenetics). In one case, it was shown to be in trans with the suspected pathogenic variant c.2269A>C (p.Ile757Leu) (Rossetti et al. 2003. PubMed ID: 12846734). The c.9530T>C (p.Ile3177Thr) variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-51612884-A-G). In conclusion, the haplotype c.[2414C>T;9530T>C] p.[Pro805Leu;Ile3177Thr] is considered to be pathogenic; however, the contribution of each variant is unknown. Although we suspect the c.9530T>C (p.Ile3177Thr) variant may be pathogenic, at this time the clinical significance of this variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.073

BayesDel_addAF

Uncertain

0.016

BayesDel_noAF

Uncertain

0.010

CADD

Benign

DANN

Uncertain

0.98

DEOGEN2

Benign

0.41

T;.

Eigen

Benign

0.075

Eigen_PC

Benign

0.19

FATHMM_MKL

Uncertain

0.96

LIST_S2

Benign

0.81

T;T

M_CAP

Uncertain

0.093

MetaRNN

Uncertain

0.53

D;D

MetaSVM

Benign

-0.55

MutationAssessor

Benign

1.8

L;L

MutationTaster

Benign

0.82

N;N

PrimateAI

Benign

0.33

PROVEAN

Benign

-2.2

N;N

REVEL

Uncertain

0.56

Sift

Uncertain

0.012

D;D

Sift4G

Uncertain

0.0040

D;D

Polyphen

0.28

B;B

Vest4

0.52

MVP

0.93

MPC

0.22

ClinPred

0.29

GERP RS

5.9

Varity_R

0.21

gMVP

0.51

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.030

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over